Is a complete BCBA/BIIB research report available?

No complete published report is available for bcba/BIIB (BCBA/BIIB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/BIIB (BCBA/BIIB)

Buenos Aires Stock Exchange: BCBA/BIIB · ARS

ARS 31,180

-860.00 (-2.7%)· Recorded snapshot

Market cap	55.5T
Revenue (ttm)	15.7T
Net income (ttm)	529.9B
EPS (ttm)	ARS 277
P/E (trailing)	112.5x
P/E (forward)	16.1x
Volume	3,802

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15.7T
Net income (ttm): 529.9B
EPS (ttm): ARS 277
P/E (trailing): 112.5x
P/E (forward): 16.1x
Market cap: 55.5T

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-28
Employees	7,500
Employees change	-105
Employees growth	-1.38%
Enterprise value	ARS 65.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1978
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARBCOM4601A8
Last earnings date	2026-10-28
Last refreshed	2026-10-29
Market cap	ARS 55.5T
Next earnings date	2026-10-29
Price	ARS 31,180.00
Price currency	ARS
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bcba/BIIB
Website	https://www.biogen.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-10-28

Employees

7,500

Employees change

-105

Employees growth

-1.38%

Enterprise value

ARS 65.5T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1978

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARBCOM4601A8

Last earnings date

2026-10-28

Last refreshed

2026-10-29

Market cap

ARS 55.5T

Next earnings date

2026-10-29

Price

ARS 31,180.00

Price currency

ARS

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

bcba/BIIB

Website

https://www.biogen.com

Metric	Value
Average P/E ratio (10Y)	19.56x
Average P/E ratio (3Y)	27.63x
Average P/E ratio (5Y)	23.52x
Earnings yield	0.89%
EV/Earnings	123.52x
EV/EBIT	17.59x
EV/EBITDA	12.44x
EV/FCF	20.73x
EV/Sales	4.13x
FCF / EV yield	4.82%
FCF yield	5.69%
Forward P/E	16.1x
Graham number	10427.28547
Graham upside	-66.56%
Lynch fair value	ARS 1,489.51
Lynch upside	-95.22%
P/(FCF - SBC) ratio	20.57x
P/(OCF - SBC) ratio	18.7x
P/B ratio	1.92x
P/E ratio	112.54x
P/FCF ratio	17.56x
P/OCF ratio	16.19x
P/S ratio	3.53x
Price/EBITDA ratio	11.01x

Metric

Value

Average P/E ratio (10Y)

19.56x

Average P/E ratio (3Y)

27.63x

Average P/E ratio (5Y)

23.52x

Earnings yield

0.89%

EV/Earnings

123.52x

EV/EBIT

17.59x

EV/EBITDA

12.44x

EV/FCF

20.73x

EV/Sales

4.13x

FCF / EV yield

4.82%

FCF yield

5.69%

Forward P/E

16.1x

Graham number

10427.28547

Graham upside

-66.56%

Lynch fair value

ARS 1,489.51

Lynch upside

-95.22%

P/(FCF - SBC) ratio

20.57x

P/(OCF - SBC) ratio

18.7x

P/B ratio

1.92x

P/E ratio

112.54x

P/FCF ratio

17.56x

P/OCF ratio

16.19x

P/S ratio

3.53x

Price/EBITDA ratio

11.01x

Metric	Value
EBIT margin	23.5%
EBITDA margin	32.07%
Effective tax rate	21.93%
FCF margin	19.89%
Gross margin	75.77%
Operating margin	23.5%
Pretax margin	4.32%
Profit margin	3.37%
Profit per employee	ARS 70.7M
Profitable quarters	2
Profitable years	22
Revenue per employee	ARS 2.1B
ROA	4.94%
ROA (5Y)	6.68%
ROCE	8.6%
ROE	1.87%
ROE (5Y)	13.26%
ROIC	7.36%
ROIC (5Y)	13.87%
SBC / revenue	2.94%
Tax / revenue	0.95%

Metric

Value

EBIT margin

23.5%

EBITDA margin

32.07%

Effective tax rate

21.93%

FCF margin

19.89%

Gross margin

75.77%

Operating margin

23.5%

Pretax margin

4.32%

Profit margin

3.37%

Profit per employee

ARS 70.7M

Profitable quarters

Profitable years

Revenue per employee

ARS 2.1B

ROA

4.94%

ROA (5Y)

6.68%

ROCE

8.6%

ROE

1.87%

ROE (5Y)

13.26%

ROIC

7.36%

ROIC (5Y)

13.87%

SBC / revenue

2.94%

Tax / revenue

0.95%

Metric	Value
EPS growth	-78.71%
EPS growth 10Y	-18.32%
EPS growth 3Y	-38.52%
EPS growth 5Y	-25.55%
EPS growth years	0
FCF growth	-10.14%
FCF growth (Q)	-51.04%
FCF growth (QoQ)	47.16%
FCF growth 3Y	24.95%
FCF growth 5Y	-0.67%
Gross profit growth	17.87%
Gross profit growth (Q)	5.59%
Gross profit growth 3Y	1.29%
Gross profit growth 5Y	-3.16%
Net income growth	-78.4%
Net income growth 3Y	-38.05%
Net income growth 5Y	-25.81%
Net income growth years	0
OCF growth	-8.42%
OCF growth (Q)	-49.64%
OCF growth (QoQ)	42.75%
OCF growth 10Y	-5.71%
OCF growth 3Y	18.23%
OCF growth 5Y	-1.59%
Operating income growth	-17.05%
Operating income growth (Q)	-12.43%
Operating income growth 3Y	5.41%
Operating income growth 5Y	-1.08%
Revenue growth	2.3%
Revenue growth (Q)	10.63%
Revenue growth (QoQ)	2.49%
Revenue growth 10Y	-1.03%
Revenue growth 3Y	1%
Revenue growth 5Y	-1.49%
Revenue growth quarters	2
Revenue growth years	1

Metric

Value

EPS growth

-78.71%

EPS growth 10Y

-18.32%

EPS growth 3Y

-38.52%

EPS growth 5Y

-25.55%

EPS growth years

FCF growth

-10.14%

FCF growth (Q)

-51.04%

FCF growth (QoQ)

47.16%

FCF growth 3Y

24.95%

FCF growth 5Y

-0.67%

Gross profit growth

17.87%

Gross profit growth (Q)

5.59%

Gross profit growth 3Y

1.29%

Gross profit growth 5Y

-3.16%

Net income growth

-78.4%

Net income growth 3Y

-38.05%

Net income growth 5Y

-25.81%

Net income growth years

OCF growth

-8.42%

OCF growth (Q)

-49.64%

OCF growth (QoQ)

42.75%

OCF growth 10Y

-5.71%

OCF growth 3Y

18.23%

OCF growth 5Y

-1.59%

Operating income growth

-17.05%

Operating income growth (Q)

-12.43%

Operating income growth 3Y

5.41%

Operating income growth 5Y

-1.08%

Revenue growth

2.3%

Revenue growth (Q)

10.63%

Revenue growth (QoQ)

2.49%

Revenue growth 10Y

-1.03%

Revenue growth 3Y

Revenue growth 5Y

-1.49%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -269B
Depreciation and amortization	ARS 1.4T
EBIT	ARS 3.7T
EBITDA	ARS 5T
EPS	ARS 277.06
Financing cash flow	ARS 1.1T
Free cash flow	ARS 3.2T
Free cash flow minus SBC	ARS 2.7T
Gross profit	ARS 11.9T
Income taxes	ARS 148.8B
Investing cash flow	ARS -8.4T
Net borrowing	ARS 961B
Net cash flow	ARS -3.9T
Net income	ARS 529.9B
Operating cash flow minus SBC	ARS 3T
Operating income	ARS 3.7T
Revenue	ARS 15.7T
Stock-based compensation	ARS 461.3B

Metric

Value

Capital expenditures

ARS -269B

Depreciation and amortization

ARS 1.4T

EBIT

ARS 3.7T

EBITDA

ARS 5T

EPS

ARS 277.06

Financing cash flow

ARS 1.1T

Free cash flow

ARS 3.2T

Free cash flow minus SBC

ARS 2.7T

Gross profit

ARS 11.9T

Income taxes

ARS 148.8B

Investing cash flow

ARS -8.4T

Net borrowing

ARS 961B

Net cash flow

ARS -3.9T

Net income

ARS 529.9B

Operating cash flow minus SBC

ARS 3T

Operating income

ARS 3.7T

Revenue

ARS 15.7T

Stock-based compensation

ARS 461.3B

Metric	Value
Altman Z-Score	2.89
Book value per share	ARS 195,225.37
Debt / EBITDA	2.28
Debt / equity	0.41
Debt / FCF	3.77
Goodwill	ARS 10.8T
Interest coverage	7.94
Long-term assets	ARS 37.2T
Long-term liabilities	ARS 14T
Net cash (debt)	ARS -9.9T
Net cash / market cap	-17.86%
Net debt / EBITDA	1.97
Net debt / equity	0.34
Net debt / FCF	3.14
Piotroski F-Score	5
Property, plant and equipment	ARS 4.8T
Shareholders' equity	ARS 28.9T
Tangible book value	ARS -2.2T
Tangible book value per share	ARS -14,964.24
Total assets	ARS 48.9T
Total cash	ARS 2T
Total debt	ARS 11.9T
Total liabilities	ARS 20T

Metric

Value

Altman Z-Score

2.89

Book value per share

ARS 195,225.37

Debt / EBITDA

2.28

Debt / equity

0.41

Debt / FCF

3.77

Goodwill

ARS 10.8T

Interest coverage

7.94

Long-term assets

ARS 37.2T

Long-term liabilities

ARS 14T

Net cash (debt)

ARS -9.9T

Net cash / market cap

-17.86%

Net debt / EBITDA

1.97

Net debt / equity

0.34

Net debt / FCF

3.14

Piotroski F-Score

Property, plant and equipment

ARS 4.8T

Shareholders' equity

ARS 28.9T

Tangible book value

ARS -2.2T

Tangible book value per share

ARS -14,964.24

Total assets

ARS 48.9T

Total cash

ARS 2T

Total debt

ARS 11.9T

Total liabilities

ARS 20T

Metric	Value
Asset turnover	0.34
Current assets	ARS 11.7T
Current liabilities	ARS 6T
Current ratio	1.95
Inventory turnover	1.13
Net working capital	ARS 4.2T
Quick ratio	0.95
Working capital	ARS 5.6T
Working capital turnover	3,365.05

Metric

Value

Asset turnover

0.34

Current assets

ARS 11.7T

Current liabilities

ARS 6T

Current ratio

1.95

Inventory turnover

1.13

Net working capital

ARS 4.2T

Quick ratio

0.95

Working capital

ARS 5.6T

Working capital turnover

3,365.05

Metric	Value
Buyback yield / dilution	-1.49%
Shareholder yield	-1.49%

Metric

Value

Buyback yield / dilution

-1.49%

Shareholder yield

-1.49%

Metric	Value
150-day SMA	ARS 24,589.67
1D price change	-2.68%
1M price change	10.18%
1M total return	10.18%
1W price change	2.97%
1W total return	2.97%
1Y price change	91.29%
1Y return CAGR	91.37%
1Y total return	91.29%
20-day SMA	ARS 29,277.00
200-day SMA	ARS 23,687.70
3M price change	26.9%
3M total return	26.9%
3Y price change	101.53%
3Y return CAGR	26.31%
3Y total return	101.53%
50-day SMA	ARS 27,914.80
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 32,880.00
52-week high date	2026-10-28
52-week low	ARS 16,090.00
52-week low date	2025-10-30
5Y price change	673.12%
5Y return CAGR	50.55%
5Y total return	673.12%
6M price change	48.12%
6M total return	48.12%
All-time high	ARS 32,880.00
All-time high date	2026-10-28
All-time low	ARS 737.00
All-time low date	2019-04-17
Average true range (ATR)	ARS 859.31
Average volume	655
Change from 52-week high	-4.24%
Change from 52-week low	107.87%
Change from all-time high	-5.17%
Change from all-time low	4,130.66%
Change from open	-2.07%
Day's gap	-0.62%
Dollar volume	ARS 118.5M
High price	ARS 32,880.00
Low price	ARS 31,000.00
Monthly RSI	76.49
Open price	ARS 31,840.00
Position in 52-week range	9.57%
Previous close	ARS 32,040.00
Price vs 150-day SMA	26.8%
Price vs 20-day SMA	6.5%
Price vs 200-day SMA	31.63%
Price vs 50-day SMA	11.7%
Relative volume	8.11
RSI	64.92
Sharpe ratio	1.68
Sharpe ratio (3Y)	0.7
Sharpe ratio (5Y)	0.98
Sortino ratio	2.7
Sortino ratio (3Y)	1.13
Sortino ratio (5Y)	1.7
Volume	3.8K
Weekly RSI	72.84
YTD price change	50.34%
YTD total return	50.34%

Metric

Value

150-day SMA

ARS 24,589.67

1D price change

-2.68%

1M price change

10.18%

1M total return

10.18%

1W price change

2.97%

1W total return

2.97%

1Y price change

91.29%

1Y return CAGR

91.37%

1Y total return

91.29%

20-day SMA

ARS 29,277.00

200-day SMA

ARS 23,687.70

3M price change

26.9%

3M total return

26.9%

3Y price change

101.53%

3Y return CAGR

26.31%

3Y total return

101.53%

50-day SMA

ARS 27,914.80

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 32,880.00

52-week high date

2026-10-28

52-week low

ARS 16,090.00

52-week low date

2025-10-30

5Y price change

673.12%

5Y return CAGR

50.55%

5Y total return

673.12%

6M price change

48.12%

6M total return

48.12%

All-time high

ARS 32,880.00

All-time high date

2026-10-28

All-time low

ARS 737.00

All-time low date

2019-04-17

Average true range (ATR)

ARS 859.31

Average volume

655

Change from 52-week high

-4.24%

Change from 52-week low

107.87%

Change from all-time high

-5.17%

Change from all-time low

4,130.66%

Change from open

-2.07%

Day's gap

-0.62%

Dollar volume

ARS 118.5M

High price

ARS 32,880.00

Low price

ARS 31,000.00

Monthly RSI

76.49

Open price

ARS 31,840.00

Position in 52-week range

9.57%

Previous close

ARS 32,040.00

Price vs 150-day SMA

26.8%

Price vs 20-day SMA

6.5%

Price vs 200-day SMA

31.63%

Price vs 50-day SMA

11.7%

Relative volume

8.11

RSI

64.92

Sharpe ratio

1.68

Sharpe ratio (3Y)

0.7

Sharpe ratio (5Y)

0.98

Sortino ratio

2.7

Sortino ratio (3Y)

1.13

Sortino ratio (5Y)

1.7

Volume

3.8K

Weekly RSI

72.84

YTD price change

50.34%

YTD total return

50.34%

Metric	Value
Float	147.2M
Shares change (QoQ)	-0.61%
Shares change (YoY)	1.49%
Shares held by insiders	0.21%
Shares held by institutions	97.64%
Short ratio	5.2 days

Metric

Value

Float

147.2M

Shares change (QoQ)

-0.61%

Shares change (YoY)

1.49%

Shares held by insiders

0.21%

Shares held by institutions

97.64%

Short ratio

5.2 days

BCBA/BIIB (BCBA/BIIB)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/BIIB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/BIIB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/BIIB

Frequently asked questions